Stem cells have been shown to be promising as a treatment for heart disease. But that’s only one part of solving the problem. Transplanted cells die after implantation due to the hostile environment they find themselves in, including the patient’s own immune system, which fights against the stem cells, even when they’re trying to help.
Researchers from Rice University and Baylor College of Medicine may have come up with an answer. They’ve developed capsules which encase mesenchymal stem cells (MSCs) in a hydrogel material made out of brown algae. This shielded approach protects the stem cells from the host, while allowing them to perform the function of delivering reparative proteins that are secreted by the cells.
“Alginate is a naturally occurring polymer found in seaweed which can form a gel in presence of divalent cations,” Omid Veiseh, assistant professor in the Department of Bioengineering at Rice University, told Digital Trends. “The material can be fabricated into spheres quite easily, using reactions which are friendly to the cells we load into the capsules. Alginate hydrogel formulations are quite prevalent in various medical products, and are also used widely in the food industry. One such example is vegan caviar. The unique aspect of our approach is that our [capsules] are formulated using a version of alginate polymer we developed that is immunomodulatory. These polymers have been chemically modified such that the body no longer recognizes the material as foreign.”
The stem cell capsules have not yet been demonstrated in humans. However, in a study carried out using rodents, the stem cells were implanted next to wounded hearts using minimally invasive techniques. Within a month, the heart healing was 2.5x greater in animals that had been given the special shielded stem cells than it was in animals which had not been given these stem cells.
“The next step is to further develop the delivery strategy for how to get the shielded stem cell into position on top of the heart using minimally invasive catheters. and further validation in chronic heart failure models,” Ravi Ghanta, associate professor of surgery at Baylor College of Medicine, told Digital Trends. “With further development and testing this approach could be utilized in a variety of cell therapies for the heart.”
A paper describing the work was recently published in the journal Biomaterials Science.
Recently, we've entered an exciting collaboration with Maple Media, creating a bundle of 17 apps worth having on your phone. From relaxed fun to serious productivity boosts, these apps cover all your bases and provide a fun boost to your phone. Normally, the bundle is $9.99 per month (far lower than the cost of using the apps individually), but for your first 7 days you can get access to the bundle for free. View the full Digital Trends App Bundle for a complete list of the apps, or read on for a summarized take.
What's happened? This week, China's Quality Certification Center released information about a battery (EB-BS04898ABY) with a maximum capacity of 4,855mAh. That's the same capacity as was previously seen in the Samsung Galaxy S25 Ultra, and fans have taken this certification to mean the Galaxy S26 Ultra will not see a capacity increase after all.
The Samsung Galaxy Ultra models have had the same battery capacity for the last five years.
What's happened? Samsung has officially announced the Galaxy Tab S10 Lite, a budget-friendly alternative to the Galaxy Tab S10. The device has been rumored for months, but this is the first time Samsung has officially acknowledged its existence.
The Galaxy Tab S10 Lite will have a 10.9-inch display and a peak brightness of 600 nits — a bit on the lower side, versus the iPad Pro's maximum brightness of 1,600 nits.